Here are six drug and medical device companies that made headlines in the past week.
1. Family of cancer victim wants another review of tossed out verdict in Johnson & Johnson talc case
The family of a woman who died of ovarian cancer is seeking another court review of a Johnson & Johnson's talcum powder case.
2. Merck attributes $135M in lost Q3 sales to NotPetya cyberattack
Merck & Co. released its third quarter earnings results Oct. 27. The company posted $10.32 billion in sales, down 2 percent from the $10.54 billion it reported during the same period last year.
3. Medline to acquire Centurion Medical Products: 4 things to know
Medline will purchase Centurion Medical Products for an undisclosed amount.
4. McKesson sends letter to president's opioid commission urging 2 specific actions
McKesson sent a letter to the President Donald Trump's Commission on Combating Drug Addiction and the Opioid Crisis, recommending the administration consider two specific actions to mitigate opioid misuse.
5. FDA: EpiPen failures attributed to 7 deaths this year
EpiPen failures — specifically their inability to deploy correctly — were linked to seven patient deaths so far this year.
6. New Jersey files opioid epidemic lawsuit against Purdue Pharma
New Jersey Attorney General Christopher Porrino filed a lawsuit against Purdue Pharma, alleging the drugmaker engaged in deceptive marketing campaigns from the late 1990s through 2007 to promote the widespread use of opioid pain medicines, including OxyContin.
Editor's note: This article was updated Nov. 11 at 3:50 p.m. to clarify there is not a causal relationship between the EpiPen malfunctions and patient deaths discussed in point No. 5.
More articles on supply chain:
6 ways the proposed Republican tax overhaul could impact pharma
2 Alere medical supply companies to close Florida facilities, lay off 182 employees
CVS Health sees operating income dip 11.5% due to reimbursement pressure, hurricanes